Tag Archives: Medicare Part D

Getting it Done in Washington

During his fifth State of the Union address, President Obama struck many familiar chords – including a line about ending certain subsidies to pharmaceutical companies – and emphasized, repeatedly, the need to get things done on the policy front. Will the sequestration drum beat goad members of the 113th Congress onto the dance floor?
Posted in healthcare, Legal, pricing, R&D, Strategy | Also tagged , , , , , , | Leave a comment

Pharma Gains from Rule On Health Insurance Benefits

Recent change likely to boost drug coverage by plans, but with variation in formularies. Health plans offering coverage to individuals and small companies are more likely to cover multiple drugs in each class or category under revised regulations proposed by the Department of Health and Human Services in November. A key change in rules to […]
Posted in healthcare, Legal, Regulatory, Strategy | Also tagged , , , | Leave a comment

Obama Deficit Plan Sides With PBMs Over Big Pharma

Amid the flurry of cost-cutting proposals aimed at guiding the Joint Select Committee on Deficit Reduction’s (Super Committee) budgetary blade, the Obama Administration has now weighed in with a proposal to cut $248 billion from Medicare spending over ten years, and $73 billion in Medicaid and other health-related spending. The Obama plan, which would increase […]
Posted in healthcare, leadership, Regulatory, Strategy | Also tagged , , , , | Leave a comment

Making Sense of US Health Reform: Some Points for the Perplexed

The March 21 passage by Congress of the Patient Protection and Affordable Care Act provides at long last a rough blueprint for driving future commercial opportunities in the second-biggest industry sector of the world’s largest economy. With over 2,400 pages of text and a phase-in timetable that extends to 2019, it is prudent to invoke […]
Posted in Op-Ed | Also tagged , , , , , , | 3 Comments
  • Categories

  • Meta